Jon Faiz Kayyem - 27 Mar 2025 Form 4 Insider Report for Inhibrx Biosciences, Inc. (INBX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
28 Mar 2025, 17:37:18 UTC
Prior SEC filing
17 Dec 2024
Next SEC filing
22 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kelly Deck, as attorney-in-fact to Jon Faiz Kayyem

Key filing fact

Jon Faiz Kayyem filed Form 4 for Inhibrx Biosciences, Inc. (INBX) on 28 Mar 2025.

Key facts

  • This page summarizes Jon Faiz Kayyem's Form 4 filing for Inhibrx Biosciences, Inc. (INBX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 28 Mar 2025, 17:37.

Change

  • Previous filing in this sequence was filed on 17 Dec 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INBX transaction

Common Stock

Gift

Transaction value
$0
Shares
-90,000
Change %
-18%
Price
$0.000000
Shares after
419,360
Date
27 Mar 2025
Ownership
By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust
Footnotes
F1, F2
INBX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
250,000
Date
27 Mar 2025
Ownership
By Jon Faiz Kayyem Revocable Trust
Footnotes
F3
INBX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
250,000
Date
27 Mar 2025
Ownership
By Paige Gates-Kayyem Revocable Trust
Footnotes
F4
INBX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
69,843
Date
27 Mar 2025
Ownership
By Child A
Footnotes
F5
INBX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
69,843
Date
27 Mar 2025
Ownership
By Child B
Footnotes
F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

This transaction involved a gift of 90,000 shares of Common Stock by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust to the reporting person's adult children not residing in the reporting person's household, and to which the reporting person does not have a beneficial interest.

Footnote F2

These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.

Footnote F3

These securities are directly owned by the Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem is the trustee.

Footnote F4

These securities are directly owned by the Paige-Gates Kayyem Revocable Trust, of which Jon Faiz Kayyem's spouse is the trustee.

Footnote F5

These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.

Footnote F6

These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .